Immunology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 27, 2024
ABSTRACT
Cancer
is
a
complex
and
heterogeneous
disease
characterised
by
uncontrolled
cell
growth
proliferation.
One
hallmark
of
cancer
cells
their
ability
to
undergo
metabolic
reprogramming,
which
allows
them
sustain
rapid
survival.
This
reprogramming
creates
an
immunosuppressive
microenvironment
that
facilitates
tumour
progression
evasion
the
immune
system.
In
this
article,
we
review
mechanisms
underlying
in
discuss
how
these
alterations
contribute
establishment
microenvironment.
We
also
explore
potential
therapeutic
strategies
targeting
vulnerabilities
enhance
immune‐mediated
anti‐tumour
responses.
Trial
Registration
ClinicalTrials.gov
identifier:
NCT02044861,
NCT03163667,
NCT04265534,
NCT02071927,
NCT02903914,
NCT03314935,
NCT03361228,
NCT03048500,
NCT03311308,
NCT03800602,
NCT04414540,
NCT02771626,
NCT03994744,
NCT03229278,
NCT04899921
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(3), P. 969 - 969
Published: Jan. 24, 2025
Breast
Cancer
(BrCa)
exhibits
a
high
phenotypic
heterogeneity,
leading
to
the
emergence
of
aggressive
clones
and
development
drug
resistance.
Considering
BrCa
heterogeneity
that
metabolic
reprogramming
is
cancer
hallmark,
we
selected
seven
cell
lines
with
diverse
subtypes
provide
their
comprehensive
metabolome
characterization:
five
commonly
used
(SK-Br-3,
T-47D,
MCF-7,
MDA-MB-436,
MDA-MB-231),
two
patient-derived
xenografts
(Hbcx39
Hbcx9).
We
characterized
endometabolomes
using
1H-NMR
spectroscopy.
found
distinct
metabolite
profiles,
certain
metabolites
being
common
but
differentially
accumulated
across
lines.
High
levels
glycine,
lactate,
glutamate,
formate,
known
promote
invasion
metastasis,
were
detected
in
all
cells.
In
our
experiment
setting
identified
unique
specific
lines:
xanthine
2-oxoglutarate
SK-Br-3,
2-oxobutyrate
cystathionine
glucose-1-phosphate
NAD+
isocitrate
MDA-MB-231,
NADP+
Hbcx9.
The
enriched
enabled
us
identify
pathways
modulated
cell-line-specific
manner,
which
may
represent
potential
candidate
targets
for
therapeutic
intervention.
believe
this
study
contribute
functional
characterization
cells
assist
selecting
appropriate
drug-response
studies.
Experimental Hematology and Oncology,
Journal Year:
2025,
Volume and Issue:
14(1)
Published: Feb. 17, 2025
Recent
studies
have
shown
that
CD32/CD8a/CD28/CD3ζ
chimeric
receptor
cells
directly
kill
breast
cancer
cells,
suggesting
the
existence
of
cell
surface
myeloid
FcγR
alternative
ligands
(ALs).
Here,
we
investigated
metabolism,
ALs,
cytotoxicity,
and
immunoregulatory
functions
CD64/CD28/CD3ζ
in
colorectal
(CRC)
squamous
carcinoma
head
neck.
The
-SFG
retroviral
vector
was
used
to
produce
viruses
for
T-cell
transduction.
expansion
differentiation
were
monitored
via
flow
cytometry.
Gene
expression
assessed
by
RNA-seq.
Bioenergetics
documented
on
a
Seahorse
extracellular
flux
analyzer.
polarization
identified
confocal
microscopy.
Cytotoxicity
determined
MTT
assay
bioluminescent
imaging,
Tridimensional
antitumor
activity
T
achieved
utilizing
HCT116-GFP
3D
spheroids
IncuCyte
S3
Live-Cell
Analysis
system.
intraperitoneal
distribution
NIR-CD64/CD28/CD3ζ
NIR-nontransduced
CB17-SCID
mice
bearing
subcutaneous
FaDu
Luc
+
fluorescent
imaging.
IFNγ
ELISA.
Compared
CD16/CD8a/CD28/CD3ζ
non-transduced
exhibited
highest
levels
persistence
capacity.
A
total
235
genes
linked
division
52
related
glycolysis
overexpressed.
glycolytic
phenotype
confirmed
functional
vitro
accompanied
preferential
effector
memory
differentiation.
Interestingly,
oxamic
acid
found
inhibit
CD64-CR
proliferation,
indicating
involvement
lactate.
Upon
conjugation
with
CRC
polarize
at
immunological
synapses,
leading
death.
SCCHN
combination
anti-B7-H3
mAb
(376.96)
or
anti-EGFR
mAb,
these
trigger
antibody-dependent
cellular
cytotoxicity
(ADCC)
under
2D
conditions.
376.96
combined
had
anti-SCCHN
vivo.
In
addition,
they
induce
upregulation
PD-L1
HLA-DR
IFNγ.
positive
anti-PD-L1
killed
ADCC,
which
enhanced
direct
cytotoxicity.
These
findings
indicate
is
involved
proliferation/expansion.
mediate
long-lasting
HLA-independent
ADCC
cells.
could
significantly
impact
rational
design
personalized
treat
identification
novel
ALs
healthy
Cells,
Journal Year:
2025,
Volume and Issue:
14(5), P. 388 - 388
Published: March 6, 2025
Metabolic
reprogramming
plays
a
crucial
role
in
cancer
biology
and
the
mechanisms
underlying
its
regulation
represent
promising
study
area.
In
this
regard,
discovery
of
non-coding
RNAs
opened
new
regulatory
landscape,
which
is
early
stages
investigation.
Using
differential
expression
model
HOTAIR,
we
evaluated
level
metabolic
enzymes,
as
well
metabolites
produced
by
glycolysis
glutaminolysis.
Our
results
demonstrated
effect
HOTAIR
on
glutaminolysis
enzymes
colorectal
cells.
Specifically,
through
overexpression
inhibition
determined
influence
PFKFB4,
PGK1,
LDHA,
SLC1A5,
GLUD1,
GOT1,
had
direct
impact
lactate
glutamate
production.
These
findings
indicate
that
significant
producing
“oncometabolites”
essential
to
maintaining
bioenergetics
biomass
necessary
for
tumor
cell
survival
regulating
Journal of Translational Medicine,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: March 6, 2025
Glioblastoma
(GBM)
patients
frequently
develop
resistance
to
temozolomide
(TMZ),
the
standard
chemotherapy.
While
targeting
cancer
metabolism
shows
promise,
relationship
between
metabolic
perturbation
and
drug
remains
poorly
understood.
We
performed
high-throughput
CRISPR
interference
screens
in
GBM
cells
identify
genes
modulating
TMZ
sensitivity.
Findings
were
validated
using
multiple
cell
lines,
patient-derived
glioma
stem
cells,
clinical
data.
Molecular
mechanisms
investigated
through
transcriptome
analysis,
profiling,
functional
assays.
identified
phosphoglycerate
kinase
1
(PGK1)
as
a
key
determinant
of
Paradoxically,
while
PGK1
inhibition
suppressed
tumor
growth,
it
enhanced
by
inducing
stress.
This
activated
AMPK
HIF-1α
pathways,
leading
DNA
damage
repair
53BP1.
expression
levels
correlated
with
sensitivity
across
models
patient
samples.
Our
study
reveals
an
unexpected
link
stress
chemoresistance,
demonstrating
how
adaptation
can
promote
therapeutic
resistance.
These
findings
caution
against
single-agent
suggest
potential
biomarker
for
response
GBM.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(9), P. 3943 - 3943
Published: April 22, 2025
The
dysregulation
of
the
Hippo
signaling
pathway
leads
to
aberrant
activation
oncogenic
YAP
and
TAZ,
driving
tumor
progression.
In
breast
cancer,
this
disruption
promotes
proliferation
metastasis.
This
study
investigates
effects
CA3,
a
selective
inhibitor,
on
proteome
triple-negative
cancer
MDA-MB-231
luminal-A-like
MCF7
cells.
Proteomic
changes
were
analyzed
via
nano-LC-MS/MS,
while
cytotoxicity,
apoptosis,
autophagy
assessed
through
WST-1
assays,
flow
cytometry,
Western
blot
analyses.
Bioinformatics
tools
employed
identify
enriched
pathways.
cells
exhibited
an
increased
expression
DNA
repair
proteins
(p
<
0.05),
indicating
compensatory
response
maintain
genomic
stability.
contrast,
showed
downregulation
factors
0.005).
Additionally,
metabolic
reprogramming
was
apparent
in
0.001).
Apoptosis
assays
revealed
rise
cell
death,
cycle
analysis
indicated
pronounced
G1-phase
arrest
0.01).
Moreover,
autophagic
suppression
particularly
evident
study,
for
first
time,
provides
evidence
that
subtypes
exhibit
distinct
dependencies
YAP-driven
pathways,
revealing
potential
therapeutic
vulnerabilities.
Targeting
alongside
or
combining
inhibition
with
blockade
luminal
holds
significant
enhance
treatment
efficacy.
Frontiers in Oncology,
Journal Year:
2025,
Volume and Issue:
15
Published: April 30, 2025
Mitochondrial
ribosomal
proteins
(MRPs)
are
essential
components
of
mitochondrial
ribosomes,
responsible
for
translating
encoded
by
DNA
and
maintaining
energy
metabolism
function.
Emerging
evidence
suggests
that
MRPs
exhibit
significant
expression
changes
in
multiple
cancer
types,
profoundly
affecting
tumor
biology
through
modulating
oxidative
stress
levels,
inducing
metabolic
reprogramming,
disrupting
cell
cycle
regulation,
inhibiting
apoptosis,
promoting
mitophagy,
remodeling
the
microenvironment.
Specifically,
have
been
implicated
proliferation,
migration,
invasion,
highlighting
their
potential
as
therapeutic
targets.
This
review
summarizes
multifaceted
roles
cancer,
focusing
on
impact
microenvironment
prognostic
biomarkers
We
also
explore
implications
precision
oncology,
particularly
patient
stratification
design
targeted
therapies,
offering
new
insights
research
directions
precise
prevention
treatment
cancer.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(10), P. 4863 - 4863
Published: May 19, 2025
Alpha-fetoprotein
(AFP)
is
a
well-known
biomarker
for
liver
cancer,
and
its
clinical
utility
widely
recognized.
Recent
studies
have
revealed
that
AFP
plays
multifaceted
role
in
various
malignant
tumors,
including
cancer.
This
suggests
not
merely
but
also
contributes
significantly
to
the
complex
process
of
tumor
formation,
emphasizing
importance
targeting
therapeutic
approaches.
Consequently,
innovative
research
development
are
essential
overcome
current
limitations
AFP-targeted
therapies,
enhance
treatment
efficacy,
minimize
side
effects.
review
explores
cancer
progression,
highlights
biological
functions
related
pathways,
discusses
implications
therapies.
Ongoing
on
will
contribute
our
understanding
mechanisms
aid
developing
effective
safe
treatments.
Ultimately,
advancements
approaches
expected
play
crucial
future
management.